How did NVZMY's recent EPS compare to expectations?
The most recent EPS for Novozymes A/S is $0.45, not beating expectations of $0.53.
How did Novozymes A/S NVZMY's revenue perform in the last quarter?
Novozymes A/S revenue for the last quarter is $0.45
What is the revenue estimate for Novozymes A/S?
According to 2 of Wall street analyst, the revenue estimate of Novozymes A/S range from $1.1B to $1.03B
What's the earning quality score for Novozymes A/S?
Novozymes A/S has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Novozymes A/S report earnings?
Novozymes A/S next earnings report is expected in 2026-05-26
What are Novozymes A/S's expected earnings?
Novozymes A/S expected earnings is $1.02B, according to wall-street analysts.
Did Novozymes A/S beat earnings expectations?
Novozymes A/S recent earnings of $996.6M beat expectations.
Key Stats
Prev.Close
$57.65
Open
$57.97
Day's Range
$57.97 - $59.14
52 week range
$49.9 - $75.99
Volume
41.6K
Avg.Volume
93.0K
Dividend yield
--
EPS (TTM)
1.45
Market Cap
$24.3B
What is NOVONESIS A S?
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..